Nilotinib
Brand name: Tasigna
Nilotinib comes in 27 pill versions in our database, in 5 strengths, from 11 manufacturers. Check the imprint to tell them apart.
Nilotinib pill images
50 mg 5 pills
- RDY 50 Nilotinib 50 mg Red, capsule, 14 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- MN5 Nilotinib 50 mg Yellow, capsule, 14 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- NVR ABL Nilotinib 50 mg Red, capsule, 12 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- APO N50 Nilotinib 50 mg Orange & yellow, capsule, 14 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- Cipla 03050mg Nilotinib 50 mg Red, capsule, 15 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
60 mg 1 pill
80 mg 1 pill
150 mg 10 pills
- RDY 150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- MN4 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- H 23 Nilotinib 150 mg Pink, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- NVR BCR Nilotinib 150 mg Red, capsule, 22 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- APO N150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- N12 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- Cipla 031150mg Nilotinib 150 mg Red, capsule, 20 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- RDY Nilotinib Hydrochloride Monohydrate 150 mg Red, capsule Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- No picture yet DIN 02368250 Nilotinib Hydrochloride Monohydrate 150 mg Tasigna, Capsule, sold in Canada Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- No picture yet DIN 02550881 Nilotinib Hydrochloride Monohydrate 150 mg Apo-Nilotinib, Capsule, sold in Canada Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
200 mg 10 pills
- RDY 200 Nilotinib 200 mg Yellow, capsule, 21 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- MN3 Nilotinib 200 mg Yellow, capsule, 21 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- H 24 Nilotinib 200 mg White, capsule, 21 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- NVR TKI Nilotinib 200 mg Yellow, capsule, 22 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- APO N200 Nilotinib 200 mg Yellow, capsule, 22 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- N11 Nilotinib 200 mg Yellow, capsule, 21 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- Cipla 032200mg Nilotinib 200 mg White, capsule, 22 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- NVR/TKI Nilotinib Hydrochloride Monohydrate 200 mg Red, capsule Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- RDY Nilotinib Hydrochloride Monohydrate 200 mg Yellow, capsule Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- No picture yet DIN 02550903 Nilotinib Hydrochloride Monohydrate 200 mg Apo-Nilotinib, Capsule, sold in Canada Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
What is Nilotinib used for?
Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Adult Patients With Newly Diagnosed Ph+ CML-CP
Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP
Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
From the FDA-approved label on DailyMed (published Sep 30, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.